Disparities in Opioid Agonist Treatment Accessibility for Priority Populations in New South Wales, Australia [0.03%]
澳大利亚新南威尔士州优先人群阿片类药物激动剂治疗的可及性差异
James H Conigrave,Timothy Dobbins,Nicholas A Buckley et al.
James H Conigrave et al.
Introduction: Opioid agonist treatment (OAT) is effective for managing opioid dependence; however, it can be hard to access in some regions. We investigated OAT access for priority populations living in New South Wales, A...
Response to "Do We Need On-Site Drug Analysis Within Supervised Injecting Facilities?" [0.03%]
对《我们在药物监管注射房里需要现场毒品分析吗？》一文的回应
Mark Bartlett,Marianne Jauncey,Jonathan Brett et al.
Mark Bartlett et al.
Development of the alcohol-free and low-alcohol drinks market in Great Britain from 2011 to 2022: Narrative timelines based on a documentary review of off-trade retail magazines and market intelligence reports [0.03%]
英国无酒精和低酒精饮料市场（2011-2022）：基于贸易零售杂志和市场情报报告的叙述时间线
Nathan Critchlow,Amber Morgan,Kathryn Angus et al.
Nathan Critchlow et al.
Issue: There is a growing alcohol-free and low-alcohol (no/lo) drinks market in Great Britain. Insight about when this emerged and how it has developed is needed to inform and interpret the growing body of research into t...
Clinicians' Perspectives on Cannabis Use and Cannabis Treatment in Clients Undertaking Opioid Dependence Treatment [0.03%]
阿片类药物依赖治疗患者的的大麻使用及大麻治疗——临床医师视角
Laila Parvaresh,Llewellyn Mills,Jaleh Gholami et al.
Laila Parvaresh et al.
Introduction: There are no prior studies investigating the perspectives of Opioid Treatment Program (OTP) clinicians on clients' cannabis use. This study examines the perspectives of OTP clinicians on patterns of cannabis...
Understanding Drug and Alcohol Staff Perspectives on the Barriers and Facilitators to Drug Checking: A Qualitative Study [0.03%]
理解药物和酒精工作人员对药物检查障碍和促进因素的观点：一项定性研究
Nina Pocuca,Brodie C Dakin,Cheneal Puljević et al.
Nina Pocuca et al.
Introduction: Drug checking (i.e., whereby members of the public submit a drug sample for pharmacological analysis of the drug content) is an evidence-based harm reduction tool. Despite this, the uptake of drug checking s...
Fetal Alcohol Spectrum Disorder: The Caring and Financial Burden to Caregivers-A Scoping Review [0.03%]
孕期饮酒谱系障碍：对照料者的关爱和经济负担-系统综述研究
Josie Tait,Anita Gibbs,Jessica McCormack et al.
Josie Tait et al.
Introduction: Fetal Alcohol Spectrum Disorder (FASD) is a lifelong neurodisability caused by exposure to alcohol in utero. It can have a severe impact on the affected child as well as their families, yet the costs associa...
Changes in the Sex/Gender Gap in Cannabis Use in Ontario, Canada From 2001 to 2019 [0.03%]
加拿大安大略省2001年至2019年大麻使用性别差距的变化
Justin Matheson,Yeshambel Nigatu,Tara Elton-Marshall et al.
Justin Matheson et al.
Introduction: Although cannabis use has been historically higher in men than women, some research suggests a narrowing of the sex/gender gap in recent decades. We characterised trends in cannabis use patterns by sex/gende...
Paul Calle
Paul Calle
The prevalence and correlates of self-reported cannabis use for medicinal, dual and recreational motives in Australia: Findings from the National Drug Strategy Household Survey 2022/2023 [0.03%]
2022-2023年澳大利亚国民药物战略家庭调查中自述的大麻医疗、双重和娱乐用途的流行率及关联因素
Danielle Dawson,Gary Chan,Daniel Stjepanović et al.
Danielle Dawson et al.
Introduction: Cannabis has been prescribed as a medicine in Australia since 2016. The current study aimed to conduct a descriptive, epidemiological investigation on the prevalence and correlates of cannabis use for differ...
Before a diagnosis of secondary catatonia due to chronic nitrous oxide use is made, all alternative causes must be ruled out [0.03%]
在作出慢性笑气使用所致继发性类固醇综合征的诊断之前，必须排除所有其他原因
João Gama Marques,Josef Finsterer
João Gama Marques